Zydus Lifesciences Limited (NSE:ZYDUSLIFE) — Stock Price

Rs1119.00 INR
▲ 0.43% today

Zydus Lifesciences Limited (NSE:ZYDUSLIFE) is currently trading at Rs1119.00 INR, up 0.43% today. Over the past 52 weeks, shares have ranged between Rs860.60 and Rs1159.00. This page tracks Zydus Lifesciences Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ZYDUSLIFE company net worth.

Zydus Lifesciences Limited (ZYDUSLIFE) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Zydus Lifesciences Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Zydus Lifesciences Limited Income Statement — Revenue, Profit & Earnings by Year

Zydus Lifesciences Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs232.41 Billion Rs195.47 Billion Rs172.37 Billion Rs151.10 Billion Rs144.03 Billion
Cost of Revenue Rs65.38 Billion Rs63.94 Billion Rs64.71 Billion Rs56.86 Billion Rs49.43 Billion
Gross Profit Rs167.03 Billion Rs131.54 Billion Rs107.67 Billion Rs94.24 Billion Rs94.60 Billion
Research & Development Rs19.45 Billion Rs13.12 Billion Rs12.41 Billion Rs10.46 Billion Rs11.25 Billion
SG&A Rs37.12 Billion Rs31.64 Billion Rs27.89 Billion Rs24.57 Billion Rs23.18 Billion
Total Operating Expenses Rs70.99 Billion Rs55.58 Billion Rs50.06 Billion Rs42.95 Billion Rs42.50 Billion
Operating Income Rs96.04 Billion Rs75.95 Billion Rs57.61 Billion Rs51.29 Billion Rs52.10 Billion
EBITDA Rs68.30 Billion Rs52.57 Billion Rs35.34 Billion Rs31.70 Billion Rs34.15 Billion
EBIT Rs59.60 Billion Rs45.39 Billion Rs28.53 Billion Rs24.74 Billion Rs27.36 Billion
Interest Expense Rs993.00 Million Rs492.00 Million Rs1.30 Billion Rs1.20 Billion Rs1.64 Billion
Income Before Tax Rs60.84 Billion Rs49.27 Billion Rs26.84 Billion Rs28.84 Billion Rs24.47 Billion
Income Tax Expense Rs14.12 Billion Rs9.78 Billion Rs5.88 Billion Rs5.12 Billion Rs1.94 Billion
Net Income Rs45.26 Billion Rs38.59 Billion Rs19.60 Billion Rs44.87 Billion Rs21.34 Billion

Zydus Lifesciences Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Zydus Lifesciences Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs372.02 Billion Rs292.81 Billion Rs257.56 Billion Rs277.95 Billion Rs238.85 Billion
Total Current Assets Rs170.46 Billion Rs114.20 Billion Rs100.16 Billion Rs120.95 Billion Rs87.16 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs70.01 Billion Rs9.67 Billion Rs7.00 Billion Rs28.47 Billion Rs4.62 Billion
Net Receivables Rs45.85 Billion Rs54.86 Billion Rs46.35 Billion Rs34.93 Billion Rs34.45 Billion
Inventory Rs39.44 Billion Rs34.42 Billion Rs34.13 Billion Rs37.19 Billion Rs32.36 Billion
Property, Plant & Equipment — — — Rs64.23 Billion Rs63.33 Billion
Goodwill Rs52.42 Billion Rs52.66 Billion Rs48.04 Billion Rs53.65 Billion Rs53.47 Billion
Total Liabilities Rs108.43 Billion Rs71.79 Billion Rs60.68 Billion Rs87.42 Billion Rs89.55 Billion
Total Current Liabilities Rs90.42 Billion Rs53.42 Billion Rs55.31 Billion Rs78.39 Billion Rs78.61 Billion
Long-term Debt — Rs0.00 Rs0.00 Rs3.62 Billion Rs6.09 Billion
Net Debt Rs2.56 Billion Rs3.91 Billion Rs7.07 Billion Rs35.63 Billion Rs39.42 Billion
Total Stockholder Equity Rs239.53 Billion Rs198.29 Billion Rs175.16 Billion Rs170.00 Billion Rs129.92 Billion
Retained Earnings Rs247.99 Billion Rs206.06 Billion Rs171.90 Billion Rs154.96 Billion Rs113.84 Billion

Zydus Lifesciences Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Zydus Lifesciences Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs67.77 Billion Rs31.96 Billion Rs26.89 Billion Rs21.04 Billion Rs32.93 Billion
Capital Expenditures Rs17.13 Billion Rs9.07 Billion Rs10.31 Billion Rs12.03 Billion Rs8.54 Billion
Free Cash Flow Rs50.64 Billion Rs23.21 Billion Rs16.58 Billion Rs9.02 Billion Rs24.39 Billion
Investing Cash Flow Rs-83.72 Billion Rs-14.75 Billion Rs11.71 Billion Rs11.54 Billion Rs-7.25 Billion
Financing Cash Flow Rs20.14 Billion Rs-17.79 Billion Rs-44.00 Billion Rs-8.68 Billion Rs-25.49 Billion
Dividends Paid Rs-3.02 Billion Rs-6.21 Billion Rs2.67 Billion Rs3.72 Billion Rs15.00 Million
Stock-Based Compensation — — — — —
Depreciation Rs9.16 Billion Rs7.64 Billion Rs7.23 Billion Rs7.36 Billion Rs7.25 Billion
Change in Cash Rs4.14 Billion Rs-748.00 Million Rs-5.34 Billion Rs23.73 Billion Rs-905.00 Million

Zydus Lifesciences Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Zydus Lifesciences Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 18, 2026 — — —
Feb 04, 2026 — 9.55 —
Nov 06, 2025 12.76 12.01 +6.24%
Aug 12, 2025 14.58 13.65 +6.81%
May 20, 2025 13.27 13.82 -3.98%
Feb 05, 2025 10.18 9.06 +12.36%
Nov 12, 2024 9.05 9.45 -4.23%
Aug 09, 2024 14.11 12.60 +11.98%